Registry for Hirschsprung Disease in Belgium
Official title: Registry for Hirschsprung Disease of the BELAPS (Belgian Association of Pediatric Surgery)
Run by Universitaire Ziekenhuizen KU Leuven · NCT04622410 · Data updated 2026-11-12
This study is collecting information about children in Belgium who have had surgery for Hirschsprung disease to see how their bowel habits change over time and to find ways to improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 18 Years |
| Sex | All |
| Enrollment | 432 (estimated) |
| Sponsor | Universitaire Ziekenhuizen KU Leuven Academic / other |
| Locations | 1 site (Leuven) |
| Status | Recruiting |
| Started | May 1, 2012 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | July 1, 2024 |
| Trial ID | NCT04622410 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are pediatric patients diagnosed with Hirschsprung disease who have undergone surgery.
✕Probably not a fit
Patients who have not been diagnosed with Hirschsprung disease or those who have not undergone surgical treatment may not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry aims to collect pre-, intra-, and postoperative data for pediatric patients with Hirschsprung disease in Belgium. The primary goal is to assess defecation habits in children 3.5 to 5.5 years after surgical intervention. Additionally, the study will evaluate long-term outcomes and identify risk factors associated with constipation and incontinence. By systematically gathering this data, the registry seeks to enhance surgical care and improve patient quality of life.
Why it matters
Potential benefit: If successful, this registry could lead to improved surgical techniques and better long-term outcomes for children with Hirschsprung disease.
How similar studies have gone: While this registry approach is common in clinical settings, the specific focus on Hirschsprung disease outcomes in Belgium may provide novel insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Hirschsprung Disease, surgery Exclusion Criteria: \-
Where it's running
-
UZ Leuven
Leuven, Belgium Recruiting
Study contacts
- Study coordinator: Colette Barle
- Email: colette.barle@uzleuven.be
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sacral nerve stimulation for children with bowel motility problems
This project tests sacral neuromodulation in children aged 3–18 with gastrointestinal motility disorders to see if imaging-guided, personalized implantation improves symptoms.
-
Nursing support to reduce parental stress for newborns with Hirschsprung's disease
This study tests whether extra nursing support can help reduce stress for parents caring for newborns with Hirschsprung's disease before their surgery.
-
Exploring nerve cell growth in children with Hirschsprung's Disease
This study is trying to see if nerve stem cells in the bowel of children with Hirschsprung's Disease can grow into healthy nerve cells to help improve their bowel function.
-
Registry for Rare Diseases
This study is creating a detailed registry to collect information on rare diseases like amyloidosis and sarcoidosis to help improve how they are diagnosed and treated.
-
Examining how different feeding methods affect gut health in newborns with gastrointestinal issues
This study is testing whether feeding newborns with gastrointestinal issues an exclusive human milk diet helps improve their gut health and feeding progress compared to standard feeding methods.
-
Long-term outcomes for children with Hirschsprung's disease and anorectal malformations
This study looks at how well children with Hirschsprung's disease and anorectal malformations are doing in the long run after their surgeries to help families understand their health and quality of life better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.